Adverse events associated with ERCP for biliary diseases; a prospective multicenter observational study.

Adverse events associated with ERCP for biliary diseases; a prospective multicenter observational study. - Adverse events associated with ERCP for biliary diseases.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024820

Enrollment

3000

Registered

2016-11-24

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse events associated with ERCP

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who underwent transpapillary ERCP for biliary diseases. 2) Patients with intact papilla. 3) Patients without history of pancreatic surgery.

Exclusion criteria

Exclusion criteria: 1) Patients with clinical evidence of acute pancreatitis at the time of the procedure. 2) Patients with altered gastrointestinal anatomy. e.g. Roux-en-Y reconstruction. 3) Patients whose ASA performance status is more than 3.

Design outcomes

Primary

Measure	Time frame
Incidence and severity of adverse events associated with ERCP.	—

Secondary

Measure	Time frame
1)Risk factors for post-ERCP pancreatitis. 2)Effectiveness of preventive procedures for post-ERCP pancreatitis.	—

Countries

Japan

Contacts

Public ContactShujiro Yazumi

The Tazuke Kofukai Medical Research Institute Kitano Hospital Department of Gastroenterology and Hepatology

s-yazumi@kitano-hp.or.jp06-6312-1221

Outcome results